Navigation Menu+

When Prescriptions Harm Patients

Posted on Sep 3, 2013 by in Personal Injury, Pharmaceutical Defects, Product Liability | 0 comments

The innovation, distribution, and sale of pharmaceuticals prove highly profitable for large pharmacy companies like Pfizer, Johnson & Johnson, and Merck. A recent 2013 study featured on CBS News states that nearly seventy percent of Americans use prescription drugs. The amount of patients relying on prescription assistance, in America alone, renders pharmaceuticals one of the most lucrative business ventures worldwide.

Among the most prescribed drugs are antidepressants, antibiotics, and painkiller opioids. In ideal scenarios, pharmaceuticals provide quick relief and healing for patients. However, prescription drugs can have adverse effects on patients which in turn lengthen recovery time. Individual biology can be a factor in a negative response to medication. However, sometimes pharmaceutical company negligence is responsible for harm caused to the patient.

Propecia and Proscar are two medicines responsible for extensive physical harm to patients. Both drugs were developed, marketed, and sold by Merck. Propecia was developed to promote hair re-growth and Proscar was developed to treat enlarged prostate. Since both drugs share the active ingredient of Finasteride patients who have taken either medicine can experience the same harmful side effects.

Side effects experienced by many Propecia and Proscar prescribers are diminished libido, erectile dysfunction, anxiety, and depression. Merck proceeded with marketing and selling these drugs while aware of the negative possible long-term side effects. For this reason, many patients who have experienced the negative drug effects are entitled to monetary compensation.

Another drug under the scrutiny of the Food and Drug Administration (FDA) is Januvia. Januvia was originally developed to help patients with type 2 diabetes. According to the website of Williams Kherkher, Januvia mimics the natural human hormones that stimulate the production of insulin. Patients who take or have taken Januvia are at a greater risk of developing pancreatitis and pancreatic duct metaplasia, a precancerous cellular change.

Patients who suffer from these pancreatic conditions may notice a loss of appetite, jaundiced skin, persistent vomiting or diarrhea, and sudden pain abdomen pain. Pancreatitis is a serious and potentially life threatening condition. If someone suffers from these symptoms and has recently been taking Januvia, they should consult legal counsel to become aware of their legal and medical options.

Submit a Comment

Your email address will not be published. Required fields are marked *